S. Mathieu

The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort *

L. Michel, F. Jean-Louis, M. Resche-Rigon, 2020, The British journal of dermatology.

P.402 WVE-210201, an investigational stereopure oligonucleotide therapy for Duchenne muscular dystrophy, induces Exon 51 skipping and dystrophin protein restoration

M. Wood, S. Standley, C. Vargeese, 2017, Neuromuscular Disorders.

Phase I Study of IPH4102, Anti‐KIR3DL2 Mab, in Relapsed/Refractory Cutaneous T‐Cell Lymphomas (CTCL): Dose‐escalation Safety, Biomarker and Clinical Activity Results

S. Whittaker, M. Khodadoust, M. Bagot, 2017 .